Wegovy 1 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F4F2R
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,793
Award facts
- Contract value 100% obligated
- $12,793.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,793.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp (Conshohocken, PA) on January 20, 2026, for Wegovy 1 mg/0.5 mL pen injections. The contract, which carries no set-aside designation, is scheduled for completion by January 21, 2026, indicating a rapid fulfillment requirement. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., one of the nation's largest pharmaceutical distributors, and fulfills this order under the parent company's substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999 through December 2031. This IDC serves as a comprehensive global pharmaceutical support vehicle enabling the delivery of brand-name and generic medications, vaccines, and medical supplies to military healthcare systems worldwide.
Wegovy, a GLP-1 receptor agonist indicated for chronic weight management, represents a specialty pharmaceutical product commonly requisitioned by military treatment facilities and veterans' healthcare programs. The rapid completion timeline suggests this delivery order fulfills an urgent medical supply need within the federal healthcare system. AmerisourceBergen's selection through competitive procurement demonstrates its established capability to meet federal pharmaceutical distribution requirements, leveraging its extensive logistics infrastructure and broad product portfolio to support Defense Health Agency operations and other government healthcare stakeholders.
Quick answers
Who was awarded contract SPE2DR26F4F2R?
SPE2DR26F4F2R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F4F2R worth?
The government has obligated $12,793 on SPE2DR26F4F2R.
Is contract SPE2DR26F4F2R an order under another contract?
Yes. SPE2DR26F4F2R is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4F2R competed?
The extent of competition for SPE2DR26F4F2R was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award